FDA Response Time For DTC Ad Advisory Comments Has Doubled, Agency Says
Executive Summary
FDA has increased from two to four weeks the time it takes to return direct-to-consumer broadcast ads with advisory comments due to the enlarged volume of submissions, Division of Drug Marketing, Advertising & Communications Branch Chief Nancy Ostrove, PhD, reported Sept. 13 at a Food & Drug Law Institute conference on "Marketing and Promotion in the New Millennium."
You may also be interested in...
FDA Phone Call Preceded Untitled Letter To Lilly Over Amyvid
Lilly promised to remove offending images from promotional materials for its imaging product, but the agency followed up with a “notice of violation” letter two months later anyway.
FDA Reminder Ad Scrutiny: Viagra Valentine, Flonase Flora Cited
FDA's ad division is looking for drug "reminder" ads that go too far in terms of implied product claims, Division of Drug Marketing, Advertising & Communications Branch Chief Nancy Ostrove, PhD, indicated at a Drug Information Association meeting in New York City Feb. 28.
FDA Reminder Ad Scrutiny: Viagra Valentine, Flonase Flora Cited
FDA's ad division is looking for drug "reminder" ads that go too far in terms of implied product claims, Division of Drug Marketing, Advertising & Communications Branch Chief Nancy Ostrove, PhD, indicated at a Drug Information Association meeting in New York City Feb. 28.